Anifrolumab (Saphnelo) listed in MB

March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024.

For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf

Lupus Blog Articles:

A Mother’s Story: Battling Lupus Alongside Her Twin Daughters

Read

Advocacy Toolkit for Individuals: Empowering the Lupus Community

Read

Supporting Lupus Canada During Canada Post Strike

Read